**Due to an update in May 2019 to the FDA.gov website, provided links may not appropriately redirect. Please visit www.fda.gov/drugs/drug-safety-and-availability to see the most recent FDA Medication Safety Alerts and Safety Communications or to search for specific alerts or communications.**
The PharmaTech recall of oral liquid docusate products has been expanded. FDA now recommends not using any liquid products manufactured by PharmaTech. The concern is potential contamination with Burkholderia cepacia. This is a new alert from the 2016 recall of all liquid docusate products manufactured by PharmaTech. Use of products contaminated with B cepacia can cause clinical infection in immunocompromised patients, especially patients with lung conditions such as cystic fibrosis. These infections can be life-threatening in certain patients. FDA received several reports of B cepacia infections in patients who were using the affected liquid docusate products. Laboratory testing by CDC found B cepacia in oral liquid docusate made by PharmaTech. Because FDA is concerned other liquid products manufactured by PharmaTech may also be contaminated, they are advising patients and healthcare professionals not to use any liquid products manufactured by PharmaTech.
The liquid products were distributed nationwide to wholesalers and retail outlets. Centurion Labs, Leader Brand, Major Pharmaceuticals, Mid Valley Pharmaceutical, and Rugby Laboratories are known distributors of PharmaTech products. The 5 suppliers have issued recalls of all liquid products manufactured by PharmaTech. Patients and healthcare facilities should stop using and quarantine these products until more is known. The affected products are likely not labeled with the name PharmaTech, making it difficult to determine if a product is potentially affected and should be quarantined. Contact the distributor of the product to determine if it was manufactured by PharmaTech. A list of some of the affected products is available on FDA’s website. In addition, a full product list from the 2016 recall is available in the August 8, 2016 FDA press release.
Additional information about the current recommendation not to use liquid PharmaTech products, including a list of some affected products and distributors:
Additional information about the recommendation not to use liquid PharmaTech products:
Additional information about the oral liquid docusate 2017 recall:
Additional information about 2016 recall: